SE8303050D0 - Pepsinliknande enzym fran humana leukocyter, forfarande for enzymets framstellning, samt terapeutiskt medel, innehallande enzymet som aktiv bestandsdel och avsett for behandling av allergisjukdomstillstand, immunkomplex - Google Patents
Pepsinliknande enzym fran humana leukocyter, forfarande for enzymets framstellning, samt terapeutiskt medel, innehallande enzymet som aktiv bestandsdel och avsett for behandling av allergisjukdomstillstand, immunkomplexInfo
- Publication number
- SE8303050D0 SE8303050D0 SE8303050A SE8303050A SE8303050D0 SE 8303050 D0 SE8303050 D0 SE 8303050D0 SE 8303050 A SE8303050 A SE 8303050A SE 8303050 A SE8303050 A SE 8303050A SE 8303050 D0 SE8303050 D0 SE 8303050D0
- Authority
- SE
- Sweden
- Prior art keywords
- enzymet
- summents
- enzym
- pep
- humana
- Prior art date
Links
- 206010020751 Hypersensitivity Diseases 0.000 title 1
- 239000004480 active ingredient Substances 0.000 title 1
- 208000026935 allergic disease Diseases 0.000 title 1
- 230000007815 allergy Effects 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 210000000265 leukocyte Anatomy 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 229940124597 therapeutic agent Drugs 0.000 title 1
- 230000000694 effects Effects 0.000 abstract 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 abstract 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 206010006187 Breast cancer Diseases 0.000 abstract 1
- 208000026310 Breast neoplasm Diseases 0.000 abstract 1
- 201000004624 Dermatitis Diseases 0.000 abstract 1
- 102000004190 Enzymes Human genes 0.000 abstract 1
- 108090000790 Enzymes Proteins 0.000 abstract 1
- 241000699670 Mus sp. Species 0.000 abstract 1
- 102000057297 Pepsin A Human genes 0.000 abstract 1
- 108090000284 Pepsin A Proteins 0.000 abstract 1
- 206010070863 Toxicity to various agents Diseases 0.000 abstract 1
- 208000024780 Urticaria Diseases 0.000 abstract 1
- 208000003455 anaphylaxis Diseases 0.000 abstract 1
- 230000003266 anti-allergic effect Effects 0.000 abstract 1
- 230000000259 anti-tumor effect Effects 0.000 abstract 1
- 208000006673 asthma Diseases 0.000 abstract 1
- 238000006243 chemical reaction Methods 0.000 abstract 1
- 229940088598 enzyme Drugs 0.000 abstract 1
- 208000030603 inherited susceptibility to asthma Diseases 0.000 abstract 1
- 208000032839 leukemia Diseases 0.000 abstract 1
- 201000008383 nephritis Diseases 0.000 abstract 1
- FEMOMIGRRWSMCU-UHFFFAOYSA-N ninhydrin Chemical compound C1=CC=C2C(=O)C(O)(O)C(=O)C2=C1 FEMOMIGRRWSMCU-UHFFFAOYSA-N 0.000 abstract 1
- 229940111202 pepsin Drugs 0.000 abstract 1
- 239000000843 powder Substances 0.000 abstract 1
- 206010043778 thyroiditis Diseases 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6478—Aspartic endopeptidases (3.4.23)
- C12N9/6481—Pepsins (3.4.23.1; 3.4.23.2; 3.4.23.3)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Dispersion Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/JP1982/000213 WO1983004260A1 (en) | 1982-05-31 | 1982-05-31 | Human leukocyte pepsin-like enzyme, and a therapeutic agent containing said enzyme as effective ingredient for treating allergic disorder, immune complex disease, and tumor |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SE8303050D0 true SE8303050D0 (sv) | 1983-05-30 |
| SE8303050L SE8303050L (sv) | 1983-12-01 |
Family
ID=13762278
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE8303050A SE8303050L (sv) | 1982-05-31 | 1983-05-30 | Pepsinliknande enzym fran humana leukocyter, forfarande for enzymets framstellning, samt terapeutiskt medel, innehallande enzymet som aktiv bestandsdel och avsett for behandling av allergisjukdomstillstand, immunkomplex |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US4591504A (sv) |
| AU (2) | AU8459882A (sv) |
| BE (1) | BE896895A (sv) |
| CA (1) | CA1207262A (sv) |
| DE (1) | DE3319360C2 (sv) |
| FR (1) | FR2527630B1 (sv) |
| GB (1) | GB2125046B (sv) |
| IT (1) | IT1172264B (sv) |
| NL (1) | NL8301934A (sv) |
| SE (1) | SE8303050L (sv) |
| WO (1) | WO1983004260A1 (sv) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5995221A (ja) * | 1982-11-20 | 1984-06-01 | Mochida Pharmaceut Co Ltd | 食細胞機能調節作用を有する医薬組成物 |
| DE3785036D1 (de) * | 1987-09-30 | 1993-04-29 | Mucos Emulsionsgesellschaft Mb | Verwendung katabolischer enzyme zur herstellung eines medikaments zum bekaempfen der erworbenen immunschwaeche (aids) und deren vorstadien (las, arc). |
| ES2038546B1 (es) * | 1991-11-08 | 1994-02-16 | Andromaco Lab | Procedimiento de obtencion de un producto de naturaleza polipeptidica con actividad inhibidora de la hiperproduccion del factor de necrosis tumoral. |
| JP2711436B2 (ja) * | 1995-02-22 | 1998-02-10 | マルホ株式会社 | アレルギー治療剤及びアレルギー対応食品 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2119872A1 (fr) * | 1970-12-30 | 1972-08-11 | Kuban Med I Im Krasnoi Armii | Produit a base de pepsine,notamment pour le traitement des maladies s'accompagnant d'une insuffisance secretoire de l'estomac |
| US3796636A (en) * | 1972-07-14 | 1974-03-12 | Wilson Pharm & Chem Corp | Process for preparing high activity pepsin |
| US4229540A (en) * | 1979-07-02 | 1980-10-21 | Cutter Laboratories, Inc. | Hydrolase purified from human plasma |
-
1982
- 1982-05-31 WO PCT/JP1982/000213 patent/WO1983004260A1/ja unknown
- 1982-05-31 AU AU84598/82A patent/AU8459882A/en not_active Abandoned
-
1983
- 1983-05-26 US US06/498,506 patent/US4591504A/en not_active Expired - Fee Related
- 1983-05-27 DE DE3319360A patent/DE3319360C2/de not_active Expired
- 1983-05-27 GB GB08314727A patent/GB2125046B/en not_active Expired
- 1983-05-27 IT IT8348383A patent/IT1172264B/it active
- 1983-05-30 SE SE8303050A patent/SE8303050L/sv not_active Application Discontinuation
- 1983-05-30 CA CA000429217A patent/CA1207262A/en not_active Expired
- 1983-05-30 AU AU15072/83A patent/AU547166B2/en not_active Ceased
- 1983-05-31 FR FR8309006A patent/FR2527630B1/fr not_active Expired
- 1983-05-31 NL NL8301934A patent/NL8301934A/nl not_active Application Discontinuation
- 1983-05-31 BE BE0/210886A patent/BE896895A/fr not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DE3319360C2 (de) | 1986-10-09 |
| GB2125046A (en) | 1984-02-29 |
| AU1507283A (en) | 1984-01-19 |
| SE8303050L (sv) | 1983-12-01 |
| FR2527630B1 (fr) | 1986-07-11 |
| AU8459882A (en) | 1983-12-16 |
| BE896895A (fr) | 1983-09-16 |
| GB8314727D0 (en) | 1983-07-06 |
| IT1172264B (it) | 1987-06-18 |
| NL8301934A (nl) | 1983-12-16 |
| FR2527630A1 (fr) | 1983-12-02 |
| DE3319360A1 (de) | 1983-12-01 |
| AU547166B2 (en) | 1985-10-10 |
| US4591504A (en) | 1986-05-27 |
| CA1207262A (en) | 1986-07-08 |
| IT8348383A0 (it) | 1983-05-27 |
| WO1983004260A1 (en) | 1983-12-08 |
| GB2125046B (en) | 1985-08-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Hara et al. | Inhibition of interleukin 1β converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage | |
| Šutovská et al. | Possible mechanisms of dose-dependent cough suppressive effect of Althaea officinalis rhamnogalacturonan in guinea pigs test system | |
| RU94034104A (ru) | Способ увеличения цитотоксичности химиотерапевтического агента, набор для лечения и средство для производства лекарств | |
| CN101928743A (zh) | 螺旋藻藻蓝蛋白的酶解产物及其应用 | |
| SE8303050D0 (sv) | Pepsinliknande enzym fran humana leukocyter, forfarande for enzymets framstellning, samt terapeutiskt medel, innehallande enzymet som aktiv bestandsdel och avsett for behandling av allergisjukdomstillstand, immunkomplex | |
| Tombolini et al. | Radiotherapy alone in elderly patients with medically inoperable stage IIIA and IIIB non-small cell lung cancer | |
| CA2292902C (en) | Use of calcitonin gene-related peptide in the prevention and alleviation of asthma and related bronchospastic pulmonary diseases | |
| WO2016036273A1 (ru) | Лекарственное средство для профилактики и лечения заболеваний дыхательных путей | |
| Enculescu | Vitamin B17/Laetrile/Amygdalin (a review). | |
| DERZAVIS et al. | TOPICAL BACITRACIN THERAPY OF PYOGENIC DERMATOSES: A Clinical Report | |
| Tung et al. | In vivo and in vitro inhibition of human histidine decarboxylase by (S)-α-fluoromethylhistidine | |
| JP2547325B2 (ja) | アレルギ−性疾患治療用外用剤 | |
| Tanaka et al. | Bell's palsy in children: analysis of clinical findings and course | |
| US4238502A (en) | Method of treating psychiatric conditions | |
| TRANQUILLITY | of surgical endeavour should benefit many patients. But it is still essential always to bear in mind that early treatment of acute middle-ear infection remains the best method of preventing the chronic condition. | |
| CA1329776C (en) | Anti-allergic extract | |
| Middleton Jr et al. | Immediate Hypersensitivity: II. Drugs in Clinical Use | |
| Cleveland | CONSECUTIVE HERPES ZOSTER AND VARICELLA, WITH VARICELLA IN A CONTACT | |
| Takahashi et al. | Serum angiotensin converting enzyme activity in human bronchial asthma | |
| Knott et al. | Penicillin Sprays and Upper Respiratory Tract Infection | |
| Alexandrova et al. | Effect of Orally Administered Ammonium Vanadate on the Immune Response of Thmour-Bearing Mice | |
| James et al. | Schistosomiasis, metriphonate, cholinesterase, and suxamethonium | |
| Saran et al. | HIV-associated cutaneous Kaposi's sarcoma—palliative local treatment by radiotherapy | |
| RU2110254C1 (ru) | Композиция для профилактики и лечения гриппа и орви | |
| CN117883465A (zh) | 一种用于神经损伤疾病及p38MAPK通路抑制剂的组合药物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NAV | Patent application has lapsed |
Ref document number: 8303050-2 Format of ref document f/p: F |